Urea-based creams for plaque and palm-sole psoriasis
Part of Skin clinical trials.
This study tests two medicated creams containing urea (a natural moisturizing ingredient) to treat psoriasis on the skin and on the palms and soles of the feet. The creams may help reduce flaking, scaling, and irritation in people with mild psoriasis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with plaque psoriasis (regular type) OR non-pustular palmoplantar psoriasis (on palms/soles) for at least 1 year
- Age 18–65 years
- Mild psoriasis (affecting less than 10% of body surface, PASI score under 10, and low impact on daily life)
- Not currently taking systemic psoriasis medications like methotrexate, cyclosporine, or apremilast
- Not currently using biologic drugs (TNF-inhibitors, IL-17 or IL-23 inhibitors) or topical steroids/calcineurin inhibitors
- Not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if adding a Chinese herbal cream to acupuncture works as well as adding a standard psoriasis cream (calcipotriol) to acupuncture. It's for people with mild to moderate plaque psoriasis and may offer a natural treatment option.
This study tests a medical device called PROXERA PSOMED 30 to see if it safely and effectively treats nail psoriasis (psoriasis affecting fingernails or toenails). If you have nail psoriasis, this trial may help determine whether this device works better than current treatments.
This trial tests if adding a fractional CO₂ laser (a type of laser that creates tiny holes in skin) to a steroid cream works better than the cream alone for treating psoriasis on the palms and soles. The goal is to see if the laser can improve stubborn hand and foot psoriasis.
This study tests a cream made from sericin (a silk protein) and turmeric to see if it helps calm psoriasis patches. It's for people with mild to moderate psoriasis that's not on sensitive areas like the face, hands, feet, or genitals, and who stop using other creams for 2 weeks before starting.
This trial tests a new topical cream for people with mild or moderate plaque psoriasis. It aims to see if the cream can improve psoriasis patches on the skin.
This study tests a new cream form of the drug apremilast for mild plaque psoriasis that covers no more than 10% of your body. It aims to see if the cream is safe and works well for treating small patches of psoriasis.
Hear when a new Plaque Type Psorisis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.